de Haan G, Dontje B, Engel C, Loeffler M, Nijhof W
Groningen Institute for Drug Studies, Department of Hematology, University of Groningen, The Netherlands.
Blood. 1995 Oct 15;86(8):2986-92.
Because of the complexity of appropriate stem cell assays, little information on the in vivo regulation of murine stem cell biology or stemmatopoiesis is available. It is unknown whether and how in vivo the primitive hematopoietic stem cell compartment is affected during a continued increased production of mature blood cells. In this study, we present data showing that prolonged (3 weeks) administration of granulocyte colony-stimulating factor (G-CSF), which is a major regulator of mature granulocyte production, has a substantial impact on both the size and the location of various stem cell subset pools in mice. We have used the novel cobblestone area forming cell (CAFC) assay to assess the effects of G-CSF on the stem cell compartment (CAFC days 7, 14, 21, and 28). In marrow, in which normally 99% of the total number of stem cells can be found, G-CSF induced a severe depletion of particularly the most primitive stem cells to 5% to 10% of normal values. The response after 7 days of G-CSF treatment was an increased amplification between CAFC day 14 and 7. However, this response occurred at the expense of the number of CAFC day 14. It is likely that the resulting gap of CAFC day 14 cell numbers was subsequently replenished from the more primitive CAFC day 21 and 28 compartments, because these cell numbers remained low during the entire treatment period. In the spleen, the number of stem cells increased, likely caused by a migration from the marrow via the blood, leading to an accumulation in the spleen. The increased number of stem cells in the spleen overcompensated for the loss in the marrow. When total body (marrow and spleen) stem cell numbers were calculated, it appeared that a continued increased production of mature granulocytes resulted in the establishment of a higher, new steady state of the stem cell compartment; most committed stem cells (CAFC day 7) were increased threefold, CAFC day 14 were increased 2.3-fold, CAFC-day 21 were increased 1.8-fold, and the most primitive stem cells evaluated, CAFC day 28, were not different from normal, although now 95% of these cells were located in the spleen. Four weeks after discontinuation of the G-CSF treatment, the stem cell reserve in the spleen had returned to a normal level, whereas stem cell numbers in marrow had recovered to values above normal. This study shows that the primitive stem cell compartment is seriously perturbed during an increased stimulation of the production of mature blood cells.(ABSTRACT TRUNCATED AT 400 WORDS)
由于合适的干细胞检测方法很复杂,关于小鼠干细胞生物学或造血干细胞生成的体内调节的信息很少。目前尚不清楚在成熟血细胞持续增加产生的过程中,原始造血干细胞区室在体内是否以及如何受到影响。在本研究中,我们提供的数据表明,粒细胞集落刺激因子(G-CSF)是成熟粒细胞生成的主要调节因子,持续(3周)给药对小鼠各种干细胞亚群池的大小和位置都有重大影响。我们使用了新型的鹅卵石区域形成细胞(CAFC)检测法来评估G-CSF对干细胞区室的影响(CAFC第7、14、21和28天)。在骨髓中,通常可以找到99%的干细胞总数,G-CSF导致特别是最原始的干细胞严重耗竭至正常值的5%至10%。G-CSF治疗7天后的反应是CAFC第14天和第7天之间的扩增增加。然而,这种反应是以CAFC第14天的数量为代价的。CAFC第14天细胞数量产生的差距可能随后由更原始的CAFC第21天和第28天的区室补充,因为在整个治疗期间这些细胞数量一直很低。在脾脏中,干细胞数量增加,可能是由于从骨髓通过血液迁移所致,导致在脾脏中积聚。脾脏中干细胞数量的增加弥补了骨髓中的损失。当计算全身(骨髓和脾脏)干细胞数量时,似乎成熟粒细胞的持续增加产生导致了干细胞区室建立了更高的新稳态;大多数定向干细胞(CAFC第7天)增加了三倍,CAFC第14天增加了2.3倍,CAFC第21天增加了1.8倍,评估的最原始干细胞CAFC第28天与正常情况没有差异,尽管现在这些细胞的95%位于脾脏中。停止G-CSF治疗四周后,脾脏中的干细胞储备已恢复到正常水平,而骨髓中的干细胞数量已恢复到高于正常的值。这项研究表明,在成熟血细胞生成增加的刺激过程中,原始干细胞区室受到严重干扰。(摘要截短至400字)